Société Summit Therapeutics plc London S.E.
Actions
GB00BN40HZ01
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Director of Finance/CFO | 46 | 01/12/19 | |
Allen Yang
CTO | Chief Tech/Sci/R&D Officer | - | 16/10/23 |
Dave Gancarz
IRC | Investor Relations Contact | - | 01/11/20 |
Bhaskar Anand
AUD | Comptroller/Controller/Auditor | 46 | - |
Campbell Hair
HRO | Human Resources Officer | - | 01/10/20 |
Betty Chang
PRN | Corporate Officer/Principal | - | 01/06/21 |
Urte Gayko
LAW | General Counsel | 53 | 03/11/21 |
Shelley Spray
PRN | Corporate Officer/Principal | 59 | 01/06/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 01/12/19 |
Robert Booth
BRD | Director/Board Member | 70 | 28/09/22 |
Director of Finance/CFO | 46 | 01/12/19 | |
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 11/11/20 |
Mostafa Ronaghi
BRD | Director/Board Member | 55 | 11/04 |
Kenneth Clark
BRD | Director/Board Member | 65 | 07/10/21 |
Director/Board Member | 63 | 15/11/22 | |
Urte Gayko
LAW | General Counsel | 53 | 03/11/21 |
Michelle Xia
BRD | Director/Board Member | 57 | 16/01/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 701 979 596 | 83 228 173 ( 11,86 %) | 0 | 11,86 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+20,03 % | 126 Md | |
+23,61 % | 117 Md | |
+22,21 % | 27,52 Md | |
-18,07 % | 20,87 Md | |
-15,10 % | 17,01 Md | |
-14,81 % | 16,26 Md | |
+9,78 % | 14,56 Md | |
-46,10 % | 15,09 Md | |
+52,34 % | 13,89 Md |